The recurrence risk of gestational diabetes according to the number of abnormal values in the oral glucose tolerance test

Primiparous women with one abnormal glucose value in the first OGTT have remarkable odds of GDM recurrence, with the odds doubling when there are two or three abnormal values during the first pregnancy. These findings can be used when planning effective counseling, prevention, and screening strategies for GDM in the subsequent pregnancy.

Authors

Institutions

Publication Details

Journal
Acta Obstetricia Et Gynecologica Scandinavica
Published
2025-05-02
DOI
https://doi.org/10.1111/aogs.15148
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The recurrence risk of gestational diabetes according to the number of abnormal values in the oral glucose tolerance test

Elina Keikkala, Tuija Männistö, Eero Kajantie, Hannele Laivuori et al.
Acta Obstetricia Et Gynecologica Scandinavica
Gestational Diabetes Research and Management
article

The recurrence risk of gestational diabetes according to the number of abnormal values in the oral glucose tolerance test

Elina Keikkala, Tuija Männistö, Eero Kajantie, Hannele Laivuori, Sanna Eteläinen, Sanna Mustaniemi, Mika Gissler, Hilkka Nikkinen, Marja Vääräsmäki, Jenni Pukkila
article en

Abstract

Primiparous women with one abnormal glucose value in the first OGTT have remarkable odds of GDM recurrence, with the odds doubling when there are two or three abnormal values during the first pregnancy. These findings can be used when planning effective counseling, prevention, and screening strategies for GDM in the subsequent pregnancy.

Acta Obstetricia Et Gynecologica ScandinavicaVol. 104(8)
University of Helsinki (FI), Tampere University (FI), University of Eastern Finland (FI), Norwegian University of Science and Technology (NO), Oulu University Hospital (FI), Helsinki University Hospital (FI), Karolinska Institutet (SE), Finnish Institute for Health and Welfare (FI), Helsinki Children's Hospital (FI), Finland University (FI), Eastern Finland Laboratory Center (FI), Tampere University Hospital (FI), Tampere University (FI), Institute for Molecular Medicine Finland (FI), University of Oulu (FI)
Helsingin ja Uudenmaan Sairaanhoitopiiri, Suomen Lääketieteen Säätiö, Yrjö Jahnssonin Säätiö, Medical Research Center Oulu, Academy of Finland, Juho Vainion Säätiö, Päivikki ja Sakari Sohlbergin Säätiö, Signe ja Ane Gyllenbergin Säätiö, Emil Aaltosen Säätiö, Lastentautien Tutkimussäätiö, Oulun Yliopisto, Sigrid Juséliuksen Säätiö, Novo Nordisk Fonden, Diabetestutkimussäätiö, Terveyden ja hyvinvoinnin laitos, Oulun Yliopistollinen Sairaala
Good health and well-being
Openalex Percentile: Top 88%
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.